跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
systemic mRNA therapy
首页
药物
systemic mRNA therapy
systemic mRNA therapy
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Cancer gene therapy based on translational control of a suicide gene
US 7592320 B2
申请人: DEBENEDETTI ARRIGO
优先权: 2001
US
4 件公开
mRNA, episomal and genomic integrated lentiviral and gammaretroviral vector expression of dimeric immunoglobulin A and polymeric immunoglobulin A to Enable Mucosal and Hematological Based Immunity/Protection via Gene Therapy for Allergens, viruses, HIV, bacteria, pneumonia, infections, pathology associated proteins, systemic pathologies, cancer, toxins and unnatural viruses. CAR engineered and non-CAR engineered immune cell expression of dimeric immunoglobulin A and polymeric immunoglobulin A.
US 2022033851 A1
申请人: SWARTZ ROGER B
优先权: 2021
US
Method for in vivo editing of KLKB1
CN 119836474 A
申请人: INTELLIA THERAPEUTICS INC
优先权: 2022
CN
LUNG-SPECIFIC MRNA DELIVERY ENABLED BY SULFONIUM LIPID NANOPARTICLES
WO 2025189135 A8
申请人: UNIV NEW YORK STATE RES FOUND
优先权: 2024
WO
药物
反馈